All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
KRYXANA 200MG TABLET_1
KRYXANA 200MG TABLET_2
KRYXANA 200MG TABLET_3
KRYXANA 200MG TABLET_1
15% Off

Kryxana 200mg Tablet

Prescription Required

Salt Composition : Ribociclib

Manufacturer : NOVARTIS INDIA LTD

Origin of Medicine : Switzerland

MRP: 23625
Price : 19990
You Save : 3635 (15%)

21 Tablet(s) In A Strip

PAP Information :    Buy 9 strips and get 3 strips Free. After buying 36 strips, Get Medicines for 3.5 years for free. Contact us for latest updates.

Pincode
Delivery By -

Patient Assistance Programs
Know About PAP

Program Overview: NOVARTIS INDIA LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Kryxana 200mg tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 9 strips of Kryxana 200mg tablet and you will receive 3 free additional strips. Therefore, if eligible, you will have to pay only Rs.180900 for twelve strips, which is Rs. 15075 per strip.

With MrMed's MRP discount of Rs.3525  per strip and Novartis PAP program, the overall savings is about Rs.1 lakhs. 

Contact us for the latest updates on this exclusive offer.

Purchase 36 strips of Kryxana 200mg tablet and you will receive 12 free additional strips. Therefore, if eligible, you will have to pay only Rs.723600 for forty eight strips, which is Rs. 15075 per strip.

With MrMed's MRP discount of Rs.3525  per strip and novartis  PAP program, the overall savings is over Rs. 4 lakhs and you will get free tablets for 3.5 years . 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the Kryxana 200mg tablet Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for ribociclib from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Novartis Ltd can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: NOVARTIS INDIA LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Kryxana 200mg tablet. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 9 strips of Kryxana 200mg tablet and you will receive 3 free additional strips. Therefore, if eligible, you will have to pay only Rs.180900 for twelve strips, which is Rs. 15075 per strip.

With MrMed's MRP discount of Rs.3525  per strip and Novartis PAP program, the overall savings is about Rs.1 lakhs. 

Contact us for the latest updates on this exclusive offer.

Purchase 36 strips of Kryxana 200mg tablet and you will receive 12 free additional strips. Therefore, if eligible, you will have to pay only Rs.723600 for forty eight strips, which is Rs. 15075 per strip.

With MrMed's MRP discount of Rs.3525  per strip and novartis  PAP program, the overall savings is over Rs. 4 lakhs and you will get free tablets for 3.5 years . 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the Kryxana 200mg tablet Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for ribociclib from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Novartis Ltd can avail of it without having to purchase the medication from MrMed.

Introduction to Kryxana 200mg Tablet

Kryxana 200mg Tablet is an anticancer medication containing the active ingredient ribociclib. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is used in women to treat a type of breast cancer (hormone receptor-positive, HER2-negative breast cancer) that is locally advanced or has spread to other parts of the body.  This medication is given in combination with other medications. It can also be used in the treatment of endometrial cancer in combination with other drugs. It works by inhibiting the activity of certain proteins, which regulate cell growth and division. By blocking these proteins, it can slow down or stop the growth of cancer cells. 

Kryxana 200mg Tablet is not recommended for adolescents and children under 18 years of age. Before taking this medication, it is vital to inform your doctor if you have any signs of infections (fever, mouth ulcers, or sore throat), liver disorders, heart disorders, or if you are allergic to peanuts or soya.  You should not drink grapefruit juice or eat grapefruits during the treatment with this Tablet.  It should not be used in persons who have a known hypersensitivity or allergy to Kryxana 200 mg Tablet or any of its components. It is important to discuss any potential contraindications with your doctor before starting treatment. Possible side effects include low white blood cell counts, fatigue, nausea, diarrhoea, and hair loss. It is only prescribed for patients who have already gone through menopause. It is not recommended for premenopausal women or for women who are pregnant or breastfeeding.


Uses of Kryxana 200mg Tablet

  • Advanced or metastatic breast cancer
  • Advanced or metastatic endometrial cancer

Therapeutic Effects of Kryxana 200mg Tablet

Ribociclib works by blocking the activity of CDK4 and CDK6 enzymes, which are involved in cell division and growth. By inhibiting these enzymes, this slows down or stops the growth of cancer cells.


Interaction of Kryxana 200mg Tablet with other drugs

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Kryxana 200mg Tablet and reduce effectiveness by causing undesirable side effects.


More Information about Kryxana 200mg Tablet

  • Kryxana 200mg Tablet tablets should be stored at room temperature between 20°C and 25°C (68°F and 77°F).
  • It should be kept dry and protected from light and moisture.
  • The tablets should be kept in the original packaging with the cap tightly closed.
  • Keep it out of reach from children and pets.
  • It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and ask them about how to reschedule the dose.

How to consume Kryxana 200mg Tablet

Kryxana 200 mg Tablet is usually taken orally, with or without food. The tablets should be swallowed whole with a glass of water and not crushed, chewed or broken. It is typically taken orally once a day with or without food, and the dosage is based on the patient's medical history and current condition. The dosage and frequency will depend on a variety of factors, including the patient's age, weight, overall health, and the type and stage of cancer being treated. It is important to follow the dosing instructions provided by a healthcare provider, and not to adjust the dosage or frequency without consulting with them first. In that case, the missed dose should be skipped and the regular dosing schedule resumed. It's important not to take a double dose to make up for a missed dose.


Safety Advices for Kryxana 200mg Tablet

Image Not Available  

Pregnancy

  

Kryxana 200mg Tablet is unsafe for pregnant women as it may cause foetal harm if taken during pregnancy. So it is recommended to avoid it during pregnancy.

Image Not Available  

Breast Feeding

  

Kryxana 200 mg Tablet is unsafe for use during breastfeeding. Because of the potential risk to the infant, breastfeeding is not recommended during treatment.

Image Not Available  

Lungs

  

Kryxana 200mg Tablet has been associated with some lung-related side effects, although these are relatively uncommon. Consult your doctor if you have any lung diseases before starting the treatment.

Image Not Available  

Liver

  

Regular monitoring of liver function tests is recommended because it has been associated with liver injury in some patients. It is important to monitor liver function regularly in patients taking Kryxana 200mg Tablet, particularly in those with pre-existing liver disease or a history of liver problems. It is unsafe for the patients having liver failure.

Image Not Available  

Alcohol

  

It is generally recommended that patients taking Kryxana 200mg Tablet avoid or limit their alcohol intake, as alcohol can increase the risk of liver damage and exacerbate any liver-related side effect.

Image Not Available  

Driving

  

Kryxana 200mg Tablet may cause side effects such as fatigue, dizziness, or blurred vision that can impair a patient's ability to drive or operate machinery safely. So it is not recommended to drive or operate machinery safely while treatment.


Side Effects of Kryxana 200mg Tablet

Side Effects:

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious:

  • Dehydration
  • Kidney problems
  • Electrolyte imbalances
  • Liver damage
  • Pneumonitis (inflammation of the lung wall)
  • Difficulty in breathing
  • Chest pain

Common:

  • Diarrhoea
  • Nausea
  • Vomiting
  • Fatigue
  • Decreased appetite
  • Abdominal pain
  • Headache
  • Respiratory tract infections
  • Anaemia
  • Increased risk of infections
  • Low white blood cell count
  • Low platelet count

Word of Advice

If you have prescribed Kryxana 200mg Tablet or any other medication, it is important to follow the instructions provided by your healthcare provider and to report any side effects or concerns promptly. It can cause serious side effects, so it is important to monitor your symptoms and seek medical attention if you experience any concerning changes in the health, such as immediate allergic reaction, nausea or vomiting. This medication can harm the fetus if used during pregnancy. Therefore, it should be avoided during pregnancy unless the potential benefits outweigh the potential risks to the fetus. If a patient becomes pregnant while taking the this tablet, they should immediately inform their healthcare provider. Pregnant women, or those who may become pregnant, should use effective contraception during treatment for at least three weeks after the last dose.  

It is important to avoid grapefruit during treatment as grapefruit reduces effectiveness of the this medication. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure that your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, it can be an effective treatment option for certain types of cancer.


FAQs

Q 1. Can Kryxana 200mg Tablet cause infertility or affect fertility in women?

Kryxana 200mg Tablet may affect fertility in women, and it is recommended to use effective contraception during treatment and for at least 21 days after the last dose. It is unclear whether it can cause permanent infertility in women.

Q 2. Is Kryxana 200mg Tablet used for?

Kryxana 200mg Tablet is primarily used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

Q 3. Can Kryxana 200mg Tablet cure breast cancer?

Kryxana 200mg Tablet is not a cure for breast cancer but can help slow the disease's progression and improve survival rates in certain cases.

Q 4. What are the signs and symptoms of liver damage associated with Kryxana 200mg Tablet?

Liver damage is a rare but serious side effect of Kryxana 200mg Tablet. Signs and symptoms of liver damage may include yellowing of the skin or eyes (jaundice), dark urine, pale stools, abdominal pain, nausea, vomiting, fatigue, or loss of appetite.

Q 5. Are there any lifestyle changes I should make while taking Kryxana 200mg Tablet?

Yes, it is important to maintain a healthy lifestyle while taking Kryxana 200mg Tablet, including eating a balanced diet, getting regular exercise, and avoiding smoking and excessive alcohol consumption.

Q 6. Can Kryxana 200mg Tablet be used in combination with other cancer treatments?

Yes, Kryxana 200mg Tablet is often used in combination with other cancer treatments, such as chemotherapy, radiation therapy, or hormonal therapy, to treat breast cancer. However, the specific treatment plan may vary depending on the individual patient's condition and response to treatment.


Fact Box of Kryxana 200mg Tablet

Molecule name: Ribociclib

 

Therapeutic class: Anticancer

Pharmacological class: Cyclin-Dependent Kinase Inhibitors

Indications: 

1. Advanced or metastatic breast cancer

2. Advanced or metastatic endometrial cancer


References

  1. Novartis Pharmaceuticals UK Ltd, Electronic medicines compendium (emc), [Revised on 18 Jan 2023], [Accessed on 29th March 2023], https://www.medicines.org.uk/emc/product/8110/smpc
  2. Novartis Pharmaceuticals, U. S National Library of Medicine, [ Revised on Dec 2022] [Accessed on 28th March 2023], https://clinicaltrials.gov/ct2/show/NCT03701334
  3. Novartis Pharmaceuticals Corporation, U.S. Food and Drug Administration. Highlights of Prescribing Information: Ribociclib. [Last revised 2017], [Accessed on 29th March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209092s000lbl.pdf
  4. Vincent T. DeVita Jr., Theodore S. Lawrence, Steven A. Rosenberg, Cancer Chemotherapy: Principles and Practice Authors, 10th Edition, 2020, 993-994

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.